When used as part of a comprehensive health strategy, microdosing GLP 1 medications can become a tool for metabolic resilience rather than a temporary solution
However, these studies did not specifically include patients with kidney disease, and the numbers of hard kidney outcomes reached (i.e., kidney transplantation, initiation of maintenance dialysis, death from kidney failure, or a sustained low GFR) were too low to make definitive conclusions on the renoprotective effects of GLP-1 receptor agonists
Reduce caloric intake Maintaining a calorie deficit (i.e., burning more calories than you take in) is a tried-and-true tactic for seeing slim-down results
March 25, 2020
Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors
A healthcare provider will evaluate your medical history, risk factors, and treatment goals to determine whether this type of treatment may be appropriate